Cited by 1,010SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAdvanced Proteomics Techniques and Applications

The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Open access

Bojkova, Denisa, Klann, Kevin, Koch, Benjamin, Widera, Marek, Krause, David, Ciesek, Sandra, Cinatl, Jindrich, Münch, Christian·2020·Nature

DOI 10.1038/s41586-020-2332-7PMC PMC7616921

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

A new coronavirus was recently discovered and named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection with SARS-CoV-2 in humans causes coronavirus disease 2019 (COVID-19) and has been rapidly spreading around the globe 1,2. SARS-CoV-2 shows some similarities to other coronaviruses; however, treatment options and an understanding of how SARS-CoV-2 infects cells are lacking. Here we identify the host cell pathways that are modulated by SARS-CoV-2 and show that inhibition of these pathways prevents viral replication in human cells. We established a human cell-culture model for infection with a clinical isolate of SARS-CoV-2. Using this cell-culture system, we determined the infection profile of SARS-CoV-2 by translatome 3 and proteome proteomics at different times after infection. These analyses revealed that SARS-CoV-2 reshapes central cellular pathways such as translation, splicing, carbon metabolism, protein homeostasis (proteostasis) and nucleic acid metabolism. Small-molecule inhibitors that target these pathways prevented viral replication in cells. Our results reveal the cellular infection profile of SARS-CoV-2 and have enabled the identification of drugs that inhibit viral replication. We anticipate that our results will guide efforts to understand the molecular mechanisms that underlie the modulation of host cells after infection with SARS-CoV-2. Furthermore, our findings provide insights for the development of therapies for the treatment of COVID-19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41586-020-2332-7

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Data Structures for Statistical Computing in Python
McKinney, W. (2010) · Proceedings of the Python in Science Conferences · doi:10.25080/majora-92bf1922-00a · Cited by 12,930
The NumPy Array: A Structure for Efficient Numerical Computation
van der Walt, S., Colbert, S. C., & Varoquaux, G. (2011) · Computing in Science & Engineering · doi:10.1109/mcse.2011.37 · Cited by 9,381
The Perseus computational platform for comprehensive analysis of (prote)omics data
Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M. Y., Geiger, T., Mann, M., & Cox, J. (2016) · Nature Methods · doi:10.1038/nmeth.3901 · Cited by 8,803
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Chan, J., Yuan, S.-F., Kok, K.-H., To, K., Chu, H., Yang, J., Xing, F., Liu, J.-L., Yip, C., Poon, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,450
A scaling normalization method for differential expression analysis of RNA-seq data
Robinson, M. D., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-3-r25 · Cited by 7,876

Show all 53 references

Sorted by citations

Items 901–998 of 998

WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v7
WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v9
CIGB-300 synthetic peptide, an antagonist of CK2 kinase activity, as a treatment for Covid-19. A computational biology approachPreprint
Miranda, J., Bringas, R., Fernández-de-Cossío, J., & Perera, Y. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.26.453805
Functional Multi-Omics Reveals Noncanonical Function of G9a in Translational Regulation of Chronic InflammationPreprint
Wang, L., Muneer, A., Xie, L., Zhang, F., Wu, B., Liu, M., Lenarcic, E. M., Feng, E. H., Song, J., Xiong, Y., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3962440
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v25
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v26
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v28
WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v14
WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v13
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v24
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v18
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v17
WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v8
WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v4
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v29
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-l393t-v34
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v22
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v27
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v23
Aptamers for Detection and Diagnostics (ADD): Can mobile systems process optical data from aptamer sensors to identify molecules indicating presence of SARS-CoV-2 virus? Should healthcare explore aptamers as drugs for prevention as well as its use as adjuvants with antibodies and vaccines?Preprint
Datta, S. (2021) · doi:10.33774/chemrxiv-2021-l393t-v34
WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v12
Peer Review #2 of "COVID-19 mortality is associated with pre-existing impaired innate immunity in health conditions (v0.2)"
(2022) · PeerJ · doi:10.7287/peerj.13227v0.2/reviews/2
Peer Review #2 of "COVID-19 mortality is associated with pre-existing impaired innate immunity in health conditions (v0.1)"
(2022) · PeerJ · doi:10.7287/peerj.13227v0.1/reviews/2
Peer Review #1 of "COVID-19 mortality is associated with pre-existing impaired innate immunity in health conditions (v0.2)"
(2022) · PeerJ · doi:10.7287/peerj.13227v0.2/reviews/1
Mitochondrial protein import motor PAM reacts on protein misfolding stress by protein import reduction and induction of PINK1-Mitophagy
Michaelis, J. B. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.69732
RandomRibo: A Novel Tool for Transcript-Level Translation Elongation Velocity Determinant Identification at Single Codon ResolutionPreprint
Parulekar-Martins, R. (2022) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/ey63f
Evolution Of SARS-CoV-2 In The Presence Of Vaccines
Marathe, V., & Yan, C. (2022) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm55620.2022.9995291
Proteomic understanding of SARS-CoV-2 infection and COVID-19: Biological, diagnostic, and therapeutic perspectives
Al‐Ejeh, F., Merhi, M., Al-Muftah, M., Fernandes, Q., Al-Zaidan, L., Bedhiafi, T., Mestiri, S., Moustafa, D., Taib, N., Inchakalody, V. P., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91794-0.00002-0
Systems biology in COVID-19
Vavougios, G. D., Zarogiannis, S. G., & Gourgoulianis, K. I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91794-0.00022-6
Proteomics of Animal Viruses
Behera, S., & Suryawanshi, A. R. (2023) · Sustainable agriculture reviews · doi:10.1007/978-3-031-21630-5_3
Statistical design and analysis of mass spectrometry-based proteomic experiments with isobaric labeling
Huang, T. C. (2021) · doi:10.17760/d20467211
Applications of multiomics data in COVID-19
Bhardwaj, T., & Somvanshi, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91794-0.00004-4
Bioinformatics Connects Life with the Universe and All the Rest
Dandekar, T., & Kunz, M. (2023) · Springer eBooks · doi:10.1007/978-3-662-65036-3_16
Metabolic Behavior of Covid-19 Infection Severity
Ferreira, V. G., Almeida, M. B., & Carrilho, E. (2023) · Springer eBooks · doi:10.1007/978-3-031-27922-5_7
Potential involvement of protein phosphatase PP2CA on protein synthesis and cell cycle during SARS-CoV-2 infection. A meta analysis investigationPreprint
Otvos, L. P., Garrito, G. I. M., & Machado, L. E. S. F. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.02.543487
Influence of Essential Amino Acids on the Synthesis of Polyproteins of the SARS-CoV-2 Virus in the COVID-19 Pathogenesis
Ponomarenko, S. V. (2023) · Health Food & Biotechnology · doi:10.36107/hfb.2023.i1.s162
Mitochondrien – Funktion und funktionelle Störungen
Müller, K. E. (2023) · Zeitschrift für Orthomolekulare Medizin · doi:10.1055/a-2099-8057
Intracellular level of HIF-1α as an indicator of the delayed impact of COVID-19 on peripheral blood lymphocytes metabolism
Zubatkina, O. V., Dobrodeeva, L. K., & Kruglov, S. D. (2023) · Экология человека · doi:10.17816/humeco409527
Development of plant-produced subunit vaccine and therapeutic protein for COVID-19
Siriwattananon, K. (2021) · Chula Digiverse · doi:10.58837/chula.the.2021.306
The high prevalence of COVID-19 in Diabetics: Unveiling the intricate interplay between viral and diabetic mechanisms
Mathew, D. (2023) · Medical Research Archives · doi:10.18103/mra.v11i10.4540
Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main proteasePreprint
Zhang, K., Eldin, P., Ciesla, J. H., Briant, L., Lentini, J. M., Ramos, J., Cobb, J., Munger, J. C., & Fu, D. (2023) · eLife · doi:10.7554/elife.90316.1
Multimodal evaluation of neuropsychiatric and cognitive dysfunctions after the SARS-CoV-2 infection (COVID-19)
Silva, L. S. (2022) · doi:10.47749/t/unicamp.2022.1261446
The Role of Changes in Structure and Dynamics of Chromatin due to COVID-19
Bigildeev, A., Alekseev, V. I., Gribkova, A. K., Timokhin, G. S., Komarova, G. A., & Shaytan, A. К. (2024) · Russian Journal of Genetics · doi:10.1134/s1022795424010034
Sharing is Caring: Drug Repurposing among Leading Diseases
García-Castillo, V., López–Urrutia, E., Pérez‐Plasencia, C., & Espinosa‐González, A. M. (2024) · Recent advances in biotechnology · doi:10.2174/9789815223163124090012
Curation and ISA representation of a SARS-Cov2/Covid-19 Proteomics Dataset - PXD107710 - ISA representation
Rocca‐Serra, P., & Sansone, S. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.3742218
Historical Perspectives of SARS-CoV-2 Viral Subversion of Host Cell: Biochemical and Pathological Aspects
Haroun, R. A., & Osman, W. H. (2023) · Applied Microbiology Theory ＆ Technology · doi:10.37256/amtt.5120243631
Vitamin D supplementation and calcium: Many-faced gods or nobody in fighting against Corona Virus Disease 2019
Roohi, A., & Gharagozlou, S. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.05.015
Time-based quantitative proteomic and phosphoproteomic analysis of A549-ACE2 cells during SARS-CoV-2 infectionPreprint
Santos, F. M., Vindel, J., Ciordia, S., Castro, V., Orera, I., Garaigorta, U., Gastaminza, P., & Corrales, F. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.20.599898
Medical computing: Computational Knowledge Vision for COVID-19 detection
Zheng, W., & Wang, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-44-321619-0.00017-0
Proteomics and COVID-19: Recent Trends
Chandarana, C. V., Prajapati, V. D., Vashi, V., & Patel, J. K. (2024) · Springer eBooks · doi:10.1007/978-3-031-64021-6_13
Identification of Peptidoglycan Glycosyltransferase FtsI as a Potential Drug Target against Salmonella Enteritidis and Salmonella Typhimurium Serovars Through Subtractive Genomics, Molecular Docking and Molecular Dynamics Simulation Approaches
Gulzar, I., Khalil, A., Ashfaq, U. A., Liaquat, S., & Haque, A. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128332400240827061932
The impact of antidiabetic medications on COVID-19 outcomes in diabetic patients: an overview
Zarei, M., Vaighan, N. S., Shiravand, S., Samani, S. M. V., Sheikholeslami, M. A., & Roudbari, Z. (2024) · Physiology and Pharmacology · doi:10.61186/phypha.28.4.363
Potential Involvement of Protein Phosphatase PPP2CA on Protein Synthesis and Cell Cycle During SARS-CoV-2 Infection: A Meta-Analysis Investigation
Otvos, L. P., Garrito, G. I. M., Jara, G. E., de Oliveira, P. S. L., & Machado, L. E. S. F. (2025) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases3010004
Immuno-μSARS2 Chip: A Peptide-Based Microarray to Assess COVID-19 Prognosis Based on Immunological Fingerprints
Guercetti, J., Alorda, M., Sappia, L. D., Galvé, R., Duran-Corbera, M., Pulido, D., Berardi, G., Royo, M., Lacoma, A., Muñoz, J., et al. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00727
Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy—Shedding of ACE2 and TMPRSS2 via ADAM10
Gutzler, C., Höhne, K., Bani, D., Kayser, G., Fähndrich, S., Ambros, M., Hug, M. J., Rieg, S., Falcone, V., Müller–Quernheim, J., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062666
Polyunsaturated Fatty Acid Imbalance‐A Contributor to SARS CoV‐2 Disease Severity
Chambers, J. P., Daum, L. T., Arulanandam, B. P., & Valdés, J. J. (2025) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/7075883
The Combination of TLR4 and TLR9 Agonists with Self-Amplifying RNA Lipid Nanoparticles Leads to a More Powerful Immune Response Against SARS-CoV-2
Keikha, R., Balali, E., Khadivi, R., & Jebali, A. (2025) · Viral Immunology · doi:10.1089/vim.2024.0099
What problem are you solving?
Wahood, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-90391-2.00089-0
Development of GFP-Expressing Infectious Clones for PRRSV Using TAR Cloning for Antiviral Drug ScreeningPreprint
Zhang, M., Qian, B., Kunec, D., & Veit, M. (2025) · Research Square · doi:10.21203/rs.3.rs-6913818/v1
In vitro evaluation and phytochemical analysis of Curcuma aeruginosa Roxb. against human coronavirus OC43
Pichetpongtorn, P., Komaikul, J., Ruangdachsuwan, S., Churod, T., Masrinoul, P., & Kitisripanya, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-06986-8
Image based subcellular mapping of the protein landscape of SARS-CoV-2 infected cells for target-centric drug repurposing
Tampere, M., Le, T. H., Asp, E., Kalman, A., Kaimal, J. M., Njenda, D. T., Bäckström, A., Axelsson, U., Xu, H., Ouyang, W., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118447
SARS-CoV-2 nucleocapsid protein delays cell cycle in S-phase
Liu, J., Liu, M., Yu, X., Wang, P., Guan, X., Huo, W., Zhang, J., Cui, M., Li, X., Zhou, X., et al. (2025) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2025.151671
Attenuate host susceptibility to respiratory virus invasion by inhibiting interactions between host proteins SLC16A3 and AP1G1
Deng, X., He, R., Zhang, J., Rao, Q., Chen, H., Huang, Z.-X., Hu, Z., Cao, S., Wang, Z., Guo, S., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.03116-24
Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases
Gao, F., Wang, D., Zuo, L., Sun, J., Dong, B., Sun, R., Shi, Y., Sun, Y., Zou, Y., Jia, Q., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327297
Cell culture pioneer Jaroslav Cinatl—the pursuit and defence of truth
Pethick, S., Wass, M. N., & Michaelis, M. (2025) · FEBS Letters · doi:10.1002/1873-3468.70204
In silico approaches to identify therapeutic drug targets against COVID-19: a detailed review with a case study
Basu, T., & Upadhyay, A. K. (2025) · In Silico Pharmacology · doi:10.1007/s40203-025-00447-w
Evolutionary rewiring of host metabolism and interferon signalling by SARS-CoV-2 variantsPreprint
Somji, R., Brown, J. C., Rowles-Khalid, S., Abdullahi, T. B., Luo, D., Barthel, N., Mülleder, M., Ralser, M., Barclay, W., Rallis, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.15.688605
Nasopharyngeal Proteomic Profiles from Patients Hospitalized Due to COVID-19 in Manaus, Amazonas, Brazil
Araújo, C. W. G. D., Vieira, C. M., Ohse, K. C., Silva, A., Cavalcante, S. A., Naveca, F. G., de Oliveira, F. M. P. B., Crainey, J. L., Lacerda, M., de Melo, G. C., et al. (2025) · COVID · doi:10.3390/covid5110192
Nanotechnology-based strategies for combating coronavirus
Ayan, S., Aranci, K., Yuka, S. A., Arayıcı, P. P., & Üstündağ, C. B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33002-5.00004-x
PermaPhosPeptide Technology: Recombinant Production of Permanently Phosphorylated Oligopeptides for 14–3–3 Protein Interactomic Studies
Perfilova, K. V., Cooley, R. B., & Sluchanko, N. N. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00531
Additional file 1 of Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Nepali, K., Sharma, R., Sharma, S., Thakur, A., & Liou, J.-P. (2022) · Figshare · doi:10.6084/m9.figshare.20962344
Comparative proteomic studies of cell membrane proteins in three cells with different susceptibility to SARS-COV-2 virus infection
Shen, L., Zhuang, H., Lin, J., Tang, X., Cao, X., Zhang, H., Khan, N. U., zhang, J., & Feng, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19720345
Additional file 1 of OmicLoupe: facilitating biological discovery by interactive exploration of multiple omic datasets and statistical comparisons
Willforss, J., Siino, V., & Levander, F. (2021) · Figshare · doi:10.6084/m9.figshare.14168638
Additional file 5 of Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
Zhou, Y., Xu, J., Hou, Y., Leverenz, J. B., Kallianpur, A. R., Mehra, R., Liu, Y., Yu, H., Pieper, A. A., Jehi, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14759706
Additional file 1 of Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
Zhou, Y., Xu, J., Hou, Y., Leverenz, J. B., Kallianpur, A. R., Mehra, R., Liu, Y., Yu, H., Pieper, A. A., Jehi, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14759694
Additional file 1 of 2-deoxy-d-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial
Bhatt, A. N., Shenoy, S., Munjal, S., Chinnadurai, V., Agarwal, A., Vinoth Kumar, A., Shanavas, A., Kanwar, R., & Chandna, S. (2022) · Figshare · doi:10.6084/m9.figshare.20438232
Additional file 1 of Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models
Mautner, L., Hoyos, M., Dangel, A., Berger, C., Ehrhardt, A., & Baiker, A. E. (2022) · Figshare · doi:10.6084/m9.figshare.19661629
Quantitative Tissue Proteomics Reveals Protein Signatures Associated with SARS-CoV-2 Variant Infection in Hamsters
Frere, J. J., Bonaventure, B., Rosberger, H., Kurland, A. P., Sachs, D. M., Patel, A. R., Garg, A. X., Gonzalez, M. G., tenOever, B. R., Lim, J. K., et al. (2026) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00851
SARS-CoV-2 E protein reduces PPARA activity in colonic and pulmonary epithelial cells, driving diarrhea and pneumonia in COVID-19
Wu, Q., Zhou, M., Feng, X., Shen, Y., Jiang, W., Liu, X., Liu, Z., Chen, M., Zhang, J., Wang, F., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116291
Multi-scale studies of Measeles virus nucleocapsid assembly
Guseva, S. (2021) · theses.fr (ABES) · doi:10.70675/3d8ab89ez161cz41aczaa94zb6e8952689fe
L'appréhension par les juges de l'Union européenne de l'incertitude scientifique
dairouty, A. E. (2021) · doi:10.70675/2191a4c4z5451z4861za351z0ea9a82833f7
Exploration of autophagy modulation in cancer and infectious diseases
Bestion, E. (2021) · theses.fr (ABES) · doi:10.70675/3663f1cdz2637z4b11za0afza7e39569a2fc
Analyse du cycle du SARS-CoV-2 en modèle cellulaire par microscopie électronique à transmission
Eymieux, S. (2023) · theses.fr (ABES) · doi:10.70675/b2613d6dz2a78z4ce7za880z900e0b790d14
Etude phénotypique des variants du SARS-CoV-2 et de leur sensibilité aux anticorps neutralisants et monoclonaux
Boschi, C. (2022) · theses.fr (ABES) · doi:10.70675/2523e81cz0815z4a31za5cczaee28bce546b
Co-prevalence of SARS-CoV-2 and Noroviruses in Wastewater Collection and Treatment Facilities of the Eastern Cape Region, South Africa: An Exacerbated Public and Environmental Health Risk Concern
Dlamini, M., Msolo, L., Nontongana, N., Ebomah, K. E., & Okoh, A. (2026) · Food and Environmnetal Virology · doi:10.1007/s12560-026-09688-0
Prediction of Drug Likeness and Synthetic Accessibility Using AI: A Case Study on Potential Therapeutic Compounds from Plants for SARS-CoV-2 Treatment
Seth, D., Debnath, S., & Pramanik, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-20428-8_5
DAMP Laden Extracellular Vesicles From the Airways of Patients With Severe SARS‐CoV‐2 Respiratory Infection Compromise Inflammation and Cellular Metabolism
Rees, A., Richards, O., Raikes, M. E., Chambers, M., Reed, S. G., Battle, C. E., Toghill, H., Newey, L., Tyler Joseph, J., An, H., et al. (2026) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70288
Goatpox virus Hrf-063 interacts with host eIF4A1 and is associated with altered expression of antiviral signaling-related factors
Long, B., Wang, H., Yu, L., Liu, B., Xu, M., AMANTAI, H., Tian, W., Chen, H., Qin, H., Han, Y., et al. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1840976
Predictive biomarkers of COVID-19 impact in renal transplant patients: an exploratory proteomic and cytokine analysis
Alaiya, A. A., Al-Mozaini, M., Shinwari, Z., Alzayed, A., Alsharif, I., Allam, R., Bakheet, R., Alharbi, L., Alotaibi, F. O., Idris, J., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1687147
Coronavirus M Protein Hijacks Toll‐Interacting Protein (TOLLIP) to Suppress NF‐κB Signaling and Promote Immune Evasion
Zhang, Y., Kang, L., Zhong, Y. D., Shao, S., Xue, S., Liu, C., Zheng, X., Lin, J., Chen, Y., Luo, F., et al. (2026) · MedComm · doi:10.1002/mco2.70821
Inhibition of RNA splicing is a novel therapeutic strategy for disruption of nuclear replicating virusesPreprint
Serra, L., O'Brien, C. M., Patterson, M. R., Otter, C. J., Yu, A., Acosta, R., Claiborne, D. T., Weiss, S. R., & Price, A. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.26.734849
Uncovering SARS-CoV-2 variant - specific dysregulation in COVID-19 breakthrough infection through salivary transcriptomics
Tyagi, S., Singh, A. K., Tyagi, N., Chaturvedi, R., & Kushwaha, H. R. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100477
Emetine dihydrochloride inhibits Chikungunya virus nsP2 helicase and shows robust antiviral activity in cells and mice
Sharma, A., Subramani, C., Shouri, K. A., Sharma, G., Basu, B., Pandey, A. D., Rout, A., Sharma, D., Jain, D., & Vrati, S. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01280-9
Host cell entry receptors as pharmacological targets in respiratory viral infections: from biology to clinical translation
El-Kafrawy, S. A., Othman, N. A., Zeyadi, M., El-Daly, M. M., & Azhar, E. I. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1904701
Proteomic analyses of seasonal human respiratory viruses unravel changes related to antiviral, inflammatory, and cell death pathways
Cerato, J. A., Madlangsakay, M. I. R., Zahedi, R. P., Porto, B. N., & Coombs, K. M. (2026) · iScience · doi:10.1016/j.isci.2026.117427
A bireporter recombinant SARS-CoV-2 Omicron BA.5 for in vitro and in vivo studies
Castro, E. M., Barre, R. S., Ye, C., Imbiakha, B., Ezzatpour, S., Čupić, A., Walter, M. R., Kobie, J. J., Plemper, R. K., García‐Sastre, A., et al. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00217-26
Programmed ribosomal frameshifting triggers translational stress to promote viral replication
Xavier, A., Kolling, M., Bourke, A. M., Mosler, T., Prieto‐Garcia, C., Karaulanov, E., Reissland, M., Tassetto, M., Kim, D., Klaassen, K., et al. (2026) · Cell · doi:10.1016/j.cell.2026.08.031 · Cited by 2
Self-citation
PhoSARte: identification of SARS-CoV-2 phosphorylation sites using contrastive learning and protein language models
Pham, N. T., Tran, D. T., Su, Q., Jung, Y., Bupi, N., Kang, D., Lee, S., & Manavalan, B. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag504

Authors: Bojkova, D., Klann, K., Koch, B., Widera, M., Krause, D., Ciesek, S., Cinatl, J., & Münch, C.
Affiliations: Goethe University Frankfurt (DE)
University Hospital Frankfurt (DE)
Corresponding author: Cinatl, Jindrich
Münch, Christian
ORCID: Klann, Kevin
Koch, Benjamin
Widera, Marek
Krause, David
Ciesek, Sandra
Cinatl, Jindrich
Münch, Christian
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2020-05-14
Volume: 583
Issue: 7816
Pages: 469-472
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/s41586-020-2332-7
PMC: PMC7616921
OpenAlex: W3026002191
Cited by: 1,010
References: 53
Citations by year: 2026: 25 · 2025: 58 · 2024: 86 · 2023: 118 · 2022: 198 · 2021: 347 · 2020: 177
FWCI: 27.46
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
Research Square (acceptedVersion, cc-by)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (submittedVersion)
Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
Funders: Frankfurter Stiftung für krebskranke Kinder
Hilfe für krebskranke Kinder Frankfurt
European Commission
Deutsche Forschungsgemeinschaft (ERC StG 803565, MU 4216/1-1, CRC 1177)
Aventis Foundation
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
Keywords: SARS-CoV-2, COVID-19 pandemic, viral replication, host-pathogen interaction, translation (biology), splicing, carbon metabolism, proteostasis, nucleic acid metabolism, small molecule inhibitors, antiviral drug targets, proteome, translatome
MeSH terms: Betacoronavirus, Proteostasis, COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Carbon, Drug Evaluation, Preclinical, Humans, Kinetics, Pneumonia, Viral, RNA Splicing, Time Factors, Protein Biosynthesis, Virus Replication, Coronavirus Infections, Caco-2 Cells, Proteome, Proteomics, Host-Pathogen Interactions, Pandemics, Molecular Targeted Therapy, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks